World Health Organization (WHO) on Monday unveiled a global Strategic Preparedness and Response Plan aimed at curbing the spread of human-to-human transmission of Mpox. The initiative came as the health agency declared, Mpox, formerly known as Monkeypox, as a global health emergency on August 14 after it spread to nearly 18 countries. Covering the period from September to February 2025, the plan outlines a funding requirement of $135 million. The funds will support coordinated global, regional, and national efforts involving WHO, Member States, the Africa Centres for Disease Control and Prevention (Africa CDC), communities, researchers, and other partners. WHO is set to launch a funding appeal soon to secure the resources needed to implement the plan effectively.WHO's Plan Focusses On Response StrategiesWHO's plan focuses on implementing comprehensive surveillance, prevention, readiness, and response strategies; advancing research and equitable access to medical countermeasures like diagnostic tests and vaccines; minimizing animal-to-human transmission; and empowering communities to actively participate in outbreak prevention and control. "Strategic vaccination efforts will focus on individuals at the highest risk, including close contacts of recent cases and healthcare workers, to interrupt transmission chains," WHO said. Africa To Get Mpox Vaccine This comes as Africa is set to receive the first batch of its Mpox vaccine this week. The continent, which is the epicentre of this viral outbreak, will receive 10,000 jabs donated by the US. Vaccines have already been made available in more than 70 countries outside Africa, but a long-drawn approval from the World Health Organization (WHO) for the procurement of jabs has made the life-saving jabs inaccessible in African countries.Mpox is a viral zoonotic disease, meaning it can be transmitted from animals to humans. It is caused by the monkeypox virus, which belongs to the Orthopoxvirus genus, the same family as the variola virus that causes smallpox. Symptoms of the disease encompass include fever, muscle aches, and sore throat. These are soon followed by skin and mucosal rashes, which typically appear within one week of exposure, but can take up to 21 days. The symptoms usually last for two to four weeks.